The Week

Albemarle (ALB) fell 4.11% this week to close at $137.36, while the S&P 500 gained 0.49%, leaving the stock about 4.6 percentage points behind the benchmark. The tape was choppy: Monday opened at $143.25 and made a weekly high of $144.055, Tuesday gapped lower and touched the weekly low of $131, midweek saw steady trade around $131-$135.49, and Friday bounced to settle at $137.36. Weekly range was 9.11% from high to low. Average daily volume of 1.71 million shares ran about 23% below the 60-day median of 2.23 million.

Key Events

DBS reiterated a buy rating early in the week. Northwestern Mutual and Bank of New York Mellon both disclosed new stakes, with BNY Mellon’s position at roughly $103.27 million. By Tuesday ALB appeared on a list of the day’s biggest US decliners, and a midweek piece titled ‘Albemarle’s Lithium Math Turns Brutal’ put lithium pricing back in focus. Chief Accounting Officer Max Hood filed an initial beneficial ownership statement. Over the weekend, a note grouped ALB with CHRW among dividend aristocrats and pointed to 20%+ upside targets ahead of key September dates. There were no earnings or product announcements from the company itself this week.

Analyst Ratings

As of 25 August, 22 institutions covered Albemarle: 10 rated it buy, 3 overweight, and 9 hold, with no sell or underweight ratings. The consensus rating is buy, and the consensus target of $172.564 sits 25.63% above the latest close of $137.36. Targets range widely from $83.28 to $225, underscoring divergent views on lithium prices. Among 37 peers in the specialty chemicals industry, ALB ranks 4th by analyst rating.

The Week Ahead

A busy macro slate starts on Monday with the Dallas Fed manufacturing index, followed on Tuesday by the S&P Global manufacturing PMI final, ISM manufacturing PMI, and JOLTS job openings. Wednesday brings ADP employment, factory orders, and EIA crude inventories. For Albemarle the key signal remains lithium pricing; the discussion around September dates and upside targets may also carry forward.

In Short

Ratings lean constructive with the consensus target about 26% above spot, but the target range spans nearly $142, reflecting deep disagreement over lithium’s bottom and recovery pace. The stock held near $131 and bounced late in the week on lighter volume and wide swings. The next test is whether lithium prices stabilise and whether the week’s macro data lift cyclical sentiment.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.